-
Fund Dashboard
- Holdings
Fidelity Advisor Biotechnology Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 362.35 mm | 1.78 mm shares | 19.26 | Common equity | Long | USA |
AMGN Amgen Inc. | 202.28 mm | 631.80 k shares | 10.75 | Common equity | Long | USA |
Fidelity Securities Lending Cash Central Fund | 164.59 mm | 164.58 mm shares | 8.75 | Short-term investment vehicle | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 94.47 mm | 112.70 k shares | 5.02 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 92.08 mm | 345.39 k shares | 4.89 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 82.06 mm | 172.40 k shares | 4.36 | Common equity | Long | USA |
ARGX argenx SE | 62.79 mm | 107.10 k shares | 3.34 | Common equity | Long | Netherlands |
ASND Ascendis Pharma A/S | 53.36 mm | 434.43 k shares | 2.84 | Common equity | Long | Denmark |
VKTX Viking Therapeutics, Inc. | 51.99 mm | 716.69 k shares | 2.76 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 45.39 mm | 426.83 k shares | 2.41 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 33.46 mm | 378.18 k shares | 1.78 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 31.10 mm | 1.44 mm shares | 1.65 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 30.28 mm | 541.07 k shares | 1.61 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 29.22 mm | 710.76 k shares | 1.55 | Common equity | Long | Canada |
CYTK Cytokinetics, Incorporated | 27.33 mm | 535.97 k shares | 1.45 | Common equity | Long | USA |
MERUS B.V.
|
26.02 mm | 521.21 k shares | 1.38 | Common equity | Long | Netherlands |
NRIX Nurix Therapeutics, Inc. | 25.48 mm | 1.04 mm shares | 1.35 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 25.14 mm | 364.70 k shares | 1.34 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 24.47 mm | 470.12 k shares | 1.30 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 21.63 mm | 256.70 k shares | 1.15 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 21.14 mm | 391.59 k shares | 1.12 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 20.48 mm | 629.47 k shares | 1.09 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 20.07 mm | 375.20 k shares | 1.07 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 18.88 mm | 663.97 k shares | 1.00 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 18.83 mm | 676.11 k shares | 1.00 | Common equity | Long | USA |
UCB SA
|
18.71 mm | 97.30 k shares | 0.99 | Common equity | Long | Belgium |
Madrigal Pharmaceuticals, Inc. | 15.59 mm | 60.10 k shares | 0.83 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 15.30 mm | 1.33 mm shares | 0.81 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 14.46 mm | 249.20 k shares | 0.77 | Common equity | Long | USA |
DNTH Dianthus Therapeutics, Inc. | 13.95 mm | 500.66 k shares | 0.74 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 13.66 mm | 466.90 k shares | 0.73 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 12.97 mm | 315.27 k shares | 0.69 | Common equity | Long | Cayman Islands |
DNLI Denali Therapeutics Inc. | 12.84 mm | 494.70 k shares | 0.68 | Common equity | Long | USA |
Fidelity Cash Central Fund | 12.46 mm | 12.45 mm shares | 0.66 | Short-term investment vehicle | Long | USA |
CATX Perspective Therapeutics, Inc. | 12.43 mm | 1.05 mm shares | 0.66 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 11.58 mm | 444.25 k shares | 0.62 | Common equity | Long | USA |
ORKA Oruka Therapeutics Inc. | 11.53 mm | 411.73 k shares | 0.61 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 11.26 mm | 89.40 k shares | 0.60 | Common equity | Long | USA |
ATXS Astria Therapeutics, Inc. | 10.94 mm | 978.74 k shares | 0.58 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 10.72 mm | 728.12 k shares | 0.57 | Common equity | Long | USA |
QTTB Q32 Bio Inc. | 9.53 mm | 201.68 k shares | 0.51 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics | 9.51 mm | 204.96 k shares | 0.51 | Common equity | Long | Cayman Islands |
TVTX Travere Therapeutics, Inc. | 9.25 mm | 528.60 k shares | 0.49 | Common equity | Long | USA |
BRIDGEBIO PHARMA INC PIPE
|
9.22 mm | 393.76 k shares | 0.49 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 9.15 mm | 423.10 k shares | 0.49 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 9.09 mm | 333.60 k shares | 0.48 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 8.35 mm | 982.76 k shares | 0.44 | Common equity | Long | USA |
CRESCENT BIOPHARMA INC PIPE
|
7.87 mm | 26.79 mm shares | 0.42 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 7.29 mm | 373.76 k shares | 0.39 | Common equity | Long | USA |
BCAX Bicara Therapeutics Inc. Common Stock | 6.76 mm | 285.52 k shares | 0.36 | Common equity | Long | USA |
WAVE LIFE SCIENCES LTD
|
6.72 mm | 490.19 k shares | 0.36 | Common equity | Long | Singapore |
DYN Dyne Therapeutics, Inc. | 6.68 mm | 231.62 k shares | 0.36 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 6.54 mm | 1.94 mm shares | 0.35 | Common equity | Long | UK |
SLNO Soleno Therapeutics, Inc. | 6.33 mm | 114.90 k shares | 0.34 | Common equity | Long | USA |
ALLK Allakos Inc. | 6.07 mm | 4.86 mm shares | 0.32 | Common equity | Long | USA |
NGNE Neurogene Inc. | 5.85 mm | 133.00 k shares | 0.31 | Common equity | Long | USA |
TECX Tectonic Therapeutic Inc | 5.85 mm | 142.60 k shares | 0.31 | Common equity | Long | USA |
ZBIO Zenas BioPharma, Inc. | 5.83 mm | 274.70 k shares | 0.31 | Common equity | Long | USA |
ANNX Annexon, Inc. | 5.79 mm | 791.65 k shares | 0.31 | Common equity | Long | USA |
SONOMA BIOTHERAPEUTICS INC SER B PFD PP | 5.67 mm | 1.97 mm shares | 0.30 | Preferred equity | Long | USA |
ARVN Arvinas, Inc. | 5.59 mm | 211.50 k shares | 0.30 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 5.30 mm | 2.07 mm shares | 0.28 | Common equity | Long | USA |
ZAI LAB LTD UNSPNRD ADR
|
5.29 mm | 175.10 k shares | 0.28 | Common equity | Long | Cayman Islands |
NMRA Neumora Therapeutics, Inc. Common Stock | 5.06 mm | 441.70 k shares | 0.27 | Common equity | Long | USA |
THRD Third Harmonic Bio, Inc. | 4.74 mm | 343.40 k shares | 0.25 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 4.73 mm | 53.10 k shares | 0.25 | Common equity | Long | USA |
BNTX BioNTech SE | 4.50 mm | 39.80 k shares | 0.24 | Common equity | Long | Germany |
CTNM Contineum Therapeutics, Inc. Class A Common Stock | 4.44 mm | 264.80 k shares | 0.24 | Common equity | Long | USA |
LRMR Larimar Therapeutics, Inc. | 4.32 mm | 524.80 k shares | 0.23 | Common equity | Long | USA |
RAPPORT THERAPEUTICS INC 180-DAY LOCK-UP LINE
|
4.10 mm | 167.05 k shares | 0.22 | Common equity | Long | USA |
MLYS Mineralys Therapeutics, Inc. | 4.04 mm | 301.70 k shares | 0.21 | Common equity | Long | USA |
ORUKA THERAPEUTICS INC PIPE
|
3.96 mm | 141.57 k shares | 0.21 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 3.94 mm | 724.72 k shares | 0.21 | Common equity | Long | USA |
ENDEAVOR BIOMEDICINES INC SERIES C PC PP | 3.78 mm | 526.64 k shares | 0.20 | Preferred equity | Long | USA |
SMMT Summit Therapeutics Inc. | 3.74 mm | 201.20 k shares | 0.20 | Common equity | Long | USA |
SVRA Savara Inc. | 3.59 mm | 986.50 k shares | 0.19 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 3.52 mm | 150.20 k shares | 0.19 | Common equity | Long | UK |
KARTOS THERAPEUTICS INC SERIES C PC PP | 3.43 mm | 530.69 k shares | 0.18 | Preferred equity | Long | USA |
SONOMA BIOTHERAPEUTICS INC SER B1 PFD PP | 3.41 mm | 1.05 mm shares | 0.18 | Preferred equity | Long | USA |
RNAC Cartesian Therapeutics, Inc. | 3.33 mm | 167.95 k shares | 0.18 | Common equity | Long | USA |
TYRA Tyra Biosciences, Inc. | 3.31 mm | 198.29 k shares | 0.18 | Common equity | Long | USA |
BRIGHT PEAK THERAPEUTICS SER B PC PP | 3.11 mm | 1.92 mm shares | 0.17 | Preferred equity | Long | USA |
TECTONIC THERAPEUTIC INC PIPE
|
2.99 mm | 72.84 k shares | 0.16 | Common equity | Long | USA |
WUGEN INC SER B PC PP | 2.44 mm | 580.28 k shares | 0.13 | Preferred equity | Long | USA |
ENLIVEN THERAPEUTICS INC PIPE
|
2.04 mm | 73.20 k shares | 0.11 | Common equity | Long | USA |
UPB Upstream Bio, Inc. | 1.97 mm | 79.60 k shares | 0.10 | Common equity | Long | USA |
CANDID THERAPEUTICS INC SER B PC PP | 1.80 mm | 1.50 mm shares | 0.10 | Preferred equity | Long | USA |
T-KNIFE THERAPEUTICS INC SER B PC PP | 1.77 mm | 1.30 mm shares | 0.09 | Preferred equity | Long | USA |
CARDURION PHARMACEUTICALS INC SER B PC PP | 1.62 mm | 331.60 k shares | 0.09 | Preferred equity | Long | USA |
ORUKA THERAPEUTICS INC SER A PC PP | 1.57 mm | 56.00 shares | 0.08 | Preferred equity | Long | USA |
ASTRIA THERAPEUTICS INC WT
|
1.47 mm | 247.63 k shares | 0.08 | Common equity | Long | USA |
PARABILIS MEDICINES INC SER D PC PP | 1.45 mm | 239.28 k shares | 0.08 | Preferred equity | Long | USA |
LIFEMINE THERAPEUTICS INC SER C PP | 1.44 mm | 1.95 mm shares | 0.08 | Preferred equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 1.40 mm | 59.90 k shares | 0.07 | Common equity | Long | USA |
BRIGHT PEAK THERAPEUTICS SER C PC PP | 995.91 k | 873.60 k shares | 0.05 | Preferred equity | Long | USA |
WUGEN INC CONV 10% 06/14/2025 PP | 871.47 k | 831.31 k principal | 0.05 | Debt | Long | USA |
JADE BIOSCIENCES INC PIPE
|
652.78 k | 131.90 k shares | 0.03 | Common equity | Long | USA |
BOUNDLESS BIO INC 144
|
554.60 k | 189.93 k shares | 0.03 | Common equity | Long | USA |
TREELINE BIOSCIENCES SERIES A PC PP | 390.80 k | 47.60 k shares | 0.02 | Preferred equity | Long | USA |
AFFERENT PHARMACEUTICALS INC CONTINGENT VALUE RT 12/31/24
|
383.16 k | 1.92 mm shares | 0.02 | Common equity | Long | USA |
ALXO ALX Oncology Holdings Inc. | 362.38 k | 253.41 k shares | 0.02 | Common equity | Long | USA |
RAPP Rapport Therapeutics, Inc. Common Stock | 328.70 k | 13.40 k shares | 0.02 | Common equity | Long | USA |
SCHOLAR ROCK HOLDING CORP WT 12/31/2025 PP
|
128.65 k | 6.00 k shares | 0.01 | Common equity | Long | USA |
STTK Shattuck Labs, Inc. | 37.31 k | 29.61 k shares | 0.00 | Common equity | Long | USA |
BOLD Boundless Bio, Inc. Common Stock | 27.45 k | 9.40 k shares | 0.00 | Common equity | Long | USA |
AFFERENT PHARMACEUTICALS INC SER C PC PP | 19.16 | 1.92 mm shares | 0.00 | Preferred equity | Long | USA |
ENLIVEN THERAPEUTICS INC CVR (NON-TRADABLE)
|
7.40 | 739.73 k shares | 0.00 | Common equity | Long | USA |